Tagged Articles

pharmaceutical company 11 articles

Generic drug maker settles whistleblower case for $500 million

MONTGOMERY, Ala.—The Alabama Attorney General’s office announced Tuesday that it participated with other states and the federal government in a $500-million settlement with India-based generic drug manufacturer Ranbaxy to resolve civil and criminal allegations that company for years made and sold dozens of adulterated prescription drugs. The company’s willful manufacture of 26 generic prescription drugs below the U.S. Food and Drug Administration’s (FDA) standards for strength, purity, and quality resulted in fraudulent claims submitted to Alabama’s Medicaid Agency as well as other state and federal health care programs. “This settlement sends a strong message to international drug manufacturers that they ... Read More

Paula Deen fesses up about her diabetes diagnosis, partnership to promote diabetes drug

Food Network star Paula Deen says she was heartbroken when, in 2009, she was diagnosed with type 2 diabetes. “I loved my life and wondered, is my whole life gong to have to change? I had umpteen cookbooks and a cooking show,” the Southern cookbook author told a full theater of fans at Florida Hospital’s Cooking to a “Healthy 100” program. Deen was asked to kick off the program and highlight menu items at 16 local eateries that vowed to serve up healthful foods. Deen was so traumatized about her diagnosis because she had built an empire – and made ... Read More

Roche questioned about unreported possible drug side effects, deaths

Roche, maker of drugs such as the cancer drug Avastin, flu medicine Tamiflu, antianxiety drug Klonopin, and the diet pill Xenical, is being investigated by European drug regulators because of potential deficiencies in the way the drug company reported possible side effects in patients in the United States. The European Medicines Agency identified the problems during a routine inspection of Roche, during which they found about 80,000 reports of possible side effects in drugs sold in the U.S. that had not been followed up on to determine if they were actual adverse reactions that should be reported to drug authorities. The ... Read More

Abbott to pay $1.5 billion for marketing Depakote for unapproved uses

Abbott Laboratories has admitted to promoting its anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration (FDA), and has agreed to pay $1.5 billion in criminal fines and civil settlement fees. Deputy Attorney General James Cole said the settlement shows the government’s determination to “hold accountable those who commit fraud.” Depakote is approved by the FDA to treat seizures as well as bipolar disorder. However, the company was found guilty of marketing the drug for unapproved uses including as a treatment for schizophrenia, agitated dementia, and autism. Abbott admitted that it trained its sales ... Read More

Panel members had financial ties to Yaz maker

Why are the birth control pills Yaz and Yasmin still on the market when studies show they are more dangerous than other oral contraceptives? Consumer watchdog group Project on Government Oversight, or POGO, claims the government’s expert panel charged with reviewing safety data on the top selling birth control pills was compromised because four members had financial ties to Bayer, the pharmaceutical company that makes the pills. The situation was a long time coming. Just as Bayer was enjoying large profits from its newer generation birth control pills and actively working to push back generic competition while formulating new folic ... Read More

Profits of diabetes drug Actos drop amid bladder cancer scare

Japan pharmaceutical company Takeda has announced a nosedive in first-half operating profits in the wake of new bladder cancer warnings on its top-selling type 2 diabetes pill Actos. The company posted a 4.8 percent drop in profits despite an April-September operating profit of ¥211 billion, the equivalent to about $2.7 billion. Takeda says part of the blame rests on currency losses from a strong yen and generic competition. However, the new warnings placed on Actos labels in Europe and the United States have caused sales of the type 2 diabetes pill to wane. New studies released within the past few ... Read More

Actos maker rolling in profits despite lawsuits questioning drug’s safety

Japanese drug maker Takeda Pharmaceutical Co., reported an 8.3 percent rise in quarterly profits last month despite new lawsuits filed by consumers who claim the company’s top-selling diabetes drug Actos caused them serious injury. Takeda booked an April-June operating profit of 116.2 billion Yen, or $1.5 billion, thanks to an increased contribution from its prescription-drugs business. Earlier this month the Food and Drug Administration (FDA) approved new warnings on the label of the type 2 diabetes drug Actos after reviewing data that showed the drug’s active ingredient, pioglitazone, may increase the risk for bladder cancer. The new safety labels recommend ... Read More

Scientists working on birth control device for men

For women, choosing a birth control method is complicated. For starters, birth control pills carry a frightening list of warnings on their safety labels. While the risks are considered remote, it’s hard to trust drug companies when they say their medication is safe. Just look at the thousands of lawsuits drug maker Bayer is facing over its top-selling oral contraceptives Yaz and Yasmin. The lawsuits claim the pharmaceutical company didn’t warn users that they were at even greater risk for deadly blood clots, heart attacks and strokes. It’s time women put the burden of contraception on the men. A team ... Read More

Beasley Allen files lawsuit against Meds IV over tainted IV fluids

Beasley Allen Law Firm has filed a lawsuit against Meds IV, the Birmingham, Ala.-based pharmaceutical company that is at the center of an IV contamination scandal that has killed nine people and sickened 10 others in six Alabama hospitals. The lawsuit was filed on behalf of Barbara Young, whose mother, Mary Ellen Kise, died at Baptist Health Systems in Prattville. “The families who have lost loved ones are not only in shock and grieving their losses, but they are concerned that this problem may be more widespread than is now known,” Jere L. Beasley, the firm’s founding shareholder, said in ... Read More

Lawsuits against Darvon, Darvocet makers expected to climb

So far, few lawsuits have been filed against the makers of the painkillers Darvon and Darvocet, but that number is expected to climb over the next few months. The drugs, which contain the ingredient propoxyphene, as well as generic equivalents, were banned late last year because new clinical studies showed the drugs were putting users at greater risk for abnormal heart rhythms. These cardiac disturbances required hospitalizations, and some patients suffered heart attacks, strokes and even sudden cardiac death. When clients contact law firms, such as Beasley Allen, a firm that is handling several of these cases, the cases are ... Read More